mRNA-3927 for propionic acidemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Nov 2021: Trial started, NCT05130437
  2. 23 Nov 2021: Trial registered, NCT05130437

The trials

NCT05130437: A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

State
Under way
Phase
Phase 1 and Phase 2
People
50 planned
Started
9 Nov 2021
Primary completion
4 Dec 2029
Arms
mRNA-3927
Results
None posted
  1. 9 Nov 2021: Trial started
  2. 23 Nov 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.